HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meike Vogler Selected Research

Cyclophosphamide (Cytoxan)

1/2018BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meike Vogler Research Topics

Disease

23Neoplasms (Cancer)
04/2024 - 11/2005
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 04/2009
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024 - 04/2018
5Rhabdomyosarcoma
10/2020 - 01/2018
4B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 05/2011
4Leukemia
04/2024 - 02/2009
3Neuroblastoma
11/2023 - 11/2005
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2009 - 11/2005
2Lymphoma (Lymphomas)
04/2024 - 01/2017
2Multiple Myeloma
01/2020 - 09/2010
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 08/2010
1Lung Neoplasms (Lung Cancer)
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2018
1Thrombocytopenia (Thrombopenia)
06/2011
1Disease Progression
04/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2009
1Glioblastoma (Glioblastoma Multiforme)
11/2005
1Residual Neoplasm
11/2005

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2009
7venetoclaxIBA
01/2021 - 01/2017
6Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
04/2024 - 05/2011
6navitoclaxIBA
11/2023 - 04/2009
4CaspasesIBA
04/2024 - 11/2005
4ABT-737IBA
06/2011 - 04/2009
3S63845IBA
11/2023 - 01/2020
2Proteasome InhibitorsIBA
01/2020 - 09/2010
2Inhibitor of Apoptosis ProteinsIBA
01/2020 - 11/2005
2Vincristine (Oncovin)FDA LinkGeneric
01/2019 - 01/2018
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019 - 05/2011
2Biomarkers (Surrogate Marker)IBA
04/2018 - 01/2017
2Apoptosis Regulatory ProteinsIBA
04/2018 - 03/2013
2Caspase 3 (Caspase-3)IBA
09/2010 - 03/2009
2LigandsIBA
03/2009 - 10/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 10/2008
1Cisplatin (Platino)FDA LinkGeneric
11/2023
1BDA-366IBA
01/2020
1guadecitabineIBA
01/2020
1tirabrutinibIBA
04/2018
1Agammaglobulinaemia Tyrosine KinaseIBA
04/2018
1S55746IBA
04/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Etoposide (VP 16)FDA LinkGeneric
01/2018
1AlpelisibIBA
01/2018
1Histone Deacetylase InhibitorsIBA
01/2018
1binimetinibIBA
01/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1Dactinomycin (Actinomycin)FDA LinkGeneric
01/2018
1Phosphotransferases (Kinase)IBA
03/2013
1Immunotoxins (Immunotoxin)IBA
03/2013
1AnnexinsIBA
09/2010
1RoscovitineIBA
09/2010
1Small Interfering RNA (siRNA)IBA
09/2010
1Bortezomib (Velcade)FDA Link
09/2010
1Propidium (Propidium Iodide)IBA
09/2010
1AlbuminsIBA
08/2010
1Cytochromes c (Cytochrome c)IBA
10/2008

Therapy/Procedure

10Therapeutics
11/2023 - 11/2005
3Immunotherapy
11/2023 - 01/2022
2Drug Therapy (Chemotherapy)
01/2019 - 04/2009
1Precision Medicine
12/2020